Sfe Investment Counsel Abbott Laboratories Transaction History

Sfe Investment Counsel

$438 Million
Q2 2024

A detailed history of Sfe Investment Counsel transactions in Abbott Laboratories stock. As of the latest transaction made, Sfe Investment Counsel holds 69,890 shares of ABT stock, worth $7.87 Million. This represents 1.66% of its overall portfolio holdings.

Number of Shares

69,890

Previous 63,949 9.29%

Holding current value

$7.87 Million

Previous $7.27 Million 0.08%

% of portfolio

1.66%

Previous 1.68%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$100.73 - $112.44 $598,436 - $668,006	5,941 Added 9.29%	69,890 $7.26 Million
Q1 2024 May 03, 2024	BUY	$109.52 - $120.96 $566,656 - $625,847	5,174 Added 8.8%	63,949 $7.27 Million
Q4 2023 Jan 31, 2024	BUY	$90.19 - $110.4 $43,742 - $53,544	485 Added 0.83%	58,775 $6.47 Million
Q3 2023 Oct 24, 2023	BUY	$95.53 - $114.62 $2,579 - $3,094	27 Added 0.05%	58,290 $5.65 Million
Q2 2023 Jul 24, 2023	BUY	$100.78 - $112.29 $18,644 - $20,773	185 Added 0.32%	58,263 $6.35 Million
Q1 2023 May 08, 2023	SELL	$96.86 - $114.01 $8,329 - $9,804	-86 Reduced 0.15%	58,078 $5.88 Million
Q4 2022 Feb 09, 2023	BUY	$95.06 - $111.52 $31,940 - $37,470	336 Added 0.58%	58,164 $6.39 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $27,092 - $31,368	280 Added 0.49%	57,828 $5.6 Million
Q2 2022 Aug 10, 2022	BUY	$102.07 - $123.37 $161,678 - $195,418	1,584 Added 2.83%	57,548 $6.25 Million
Q1 2022 May 06, 2022	SELL	$114.02 - $139.04 $63,737 - $77,723	-559 Reduced 0.99%	55,964 $6.62 Million
Q4 2021 Feb 07, 2022	BUY	$115.53 - $141.46 $63,541 - $77,803	550 Added 0.98%	56,523 $7.96 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $92,394 - $102,215	-792 Reduced 1.4%	55,973 $6.61 Million
Q2 2021 Aug 10, 2021	BUY	$105.79 - $124.53 $92,460 - $108,839	874 Added 1.56%	56,765 $6.58 Million
Q1 2021 Apr 30, 2021	SELL	$108.84 - $128.23 $18,176 - $21,414	-167 Reduced 0.3%	55,891 $6.7 Million
Q4 2020 Feb 04, 2021	BUY	$105.0 - $114.42 $422,835 - $460,769	4,027 Added 7.74%	56,058 $6.14 Million
Q3 2020 Nov 09, 2020	SELL	$91.64 - $111.29 $157,895 - $191,752	-1,723 Reduced 3.21%	52,031 $5.66 Million
Q2 2020 Aug 05, 2020	SELL	$76.57 - $98.0 $230,322 - $294,784	-3,008 Reduced 5.3%	53,754 $4.92 Million
Q1 2020 May 04, 2020	SELL	$62.82 - $91.86 $1.44 Million - $2.1 Million	-22,849 Reduced 28.7%	56,762 $4.48 Million
Q4 2019 Jan 17, 2020	SELL	$78.51 - $87.4 $50,167 - $55,848	-639 Reduced 0.8%	79,611 $6.92 Million
Q3 2019 Oct 31, 2019	SELL	$81.84 - $88.74 $475,654 - $515,756	-5,812 Reduced 6.75%	80,250 $6.72 Million
Q2 2019 Jul 26, 2019	SELL	$72.88 - $85.0 $180,596 - $210,630	-2,478 Reduced 2.8%	86,062 $7.24 Million
Q1 2019 May 08, 2019	SELL	$66.22 - $80.06 $636,175 - $769,136	-9,607 Reduced 9.79%	88,540 $7.08 Million
Q4 2018 Feb 07, 2019	SELL	$65.56 - $74.27 $665,696 - $754,137	-10,154 Reduced 9.38%	98,147 $7.1 Million
Q3 2018 Oct 31, 2018	SELL	$60.81 - $73.36 $160,051 - $193,083	-2,632 Reduced 2.37%	108,301 $7.95 Million
Q2 2018 Jul 30, 2018	SELL	$57.57 - $63.54 $341,793 - $377,236	-5,937 Reduced 5.08%	110,933 $6.77 Million
Q1 2018 May 01, 2018	SELL	$56.27 - $63.62 $432,153 - $488,601	-7,680 Reduced 6.17%	116,870 $7 Million
Q4 2017 Feb 06, 2018	SELL	$53.68 - $57.47 $123,732 - $132,468	-2,305 Reduced 1.82%	124,550 $7.11 Million
Q3 2017 Nov 01, 2017	BUY	$48.06 - $53.64 $6.1 Million - $6.8 Million	126,855	126,855 $6.77 Million

Others Institutions Holding ABT

# of Institutions

3,137

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sfe Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Sfe Investment Counsel with notifications on news.

Account

Sfe Investment Counsel Abbott Laboratories Transaction History